SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.

Autres langues Shanghai Allist Pharmaceuticals Co., Ltd.

Actions

688578

CNE100005XJ7

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 23/05/2024			Varia. 5j.	Varia. 1 janv.
57,25 ^CNY	-3,33 %		-3,91 %	+37,42 %

09/05	Un médicament anticancéreux d'Abbisko Cayman sera testé cliniquement en combinaison avec le Furmonertinib de Shanghai Allist	MT
25/04	Shanghai Allist Pharmaceuticals Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib	09/05
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib	01/04
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Shanghai Allist Pharmaceuticals Co., Ltd.(XSSC:688578) added to S&P Global BMI Index	18/09/23
InnoCare Announces Approval of Clinical Trial of SHP2 Inhibitor ICP-189 in Combination with EGFR Inhibitor Furmonertinib	14/09/23
Allist Pharmaceuticals Co., Ltd. and ArriVent Biopharma, Inc. Announce Interim Results from Ongoing Phase 1B Trial with Furmonertinib At the 2023 World Conference on Lung Cancer	10/09/23
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Shanghai Allist Pharmaceuticals Gets Nod to Advance Trial of Lung Cancer Treatment	23/08/23
Chinese healthcare stocks hit by stepped up anti-graft crackdown	09/08/23
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action 688578
Actualités Shanghai Allist Pharmaceuticals Co., Ltd.
Autres langues

-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.

PROFITEZ-EN MAINTENANT